| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Computed Tomography Angiography | 50 | 2023 | 424 | 5.930 |
Why?
|
| Coronary Artery Disease | 36 | 2022 | 696 | 4.800 |
Why?
|
| Contrast Media | 46 | 2022 | 595 | 4.580 |
Why?
|
| Magnetic Resonance Angiography | 17 | 2021 | 181 | 4.310 |
Why?
|
| Coronary Angiography | 50 | 2023 | 866 | 3.980 |
Why?
|
| Magnetic Resonance Imaging | 31 | 2022 | 2223 | 3.820 |
Why?
|
| Tomography, X-Ray Computed | 53 | 2023 | 2324 | 3.280 |
Why?
|
| Coronary Stenosis | 19 | 2023 | 246 | 2.920 |
Why?
|
| Peripheral Arterial Disease | 6 | 2021 | 83 | 2.920 |
Why?
|
| Heart | 15 | 2022 | 850 | 2.830 |
Why?
|
| Fractional Flow Reserve, Myocardial | 14 | 2022 | 137 | 2.660 |
Why?
|
| Transcatheter Aortic Valve Replacement | 11 | 2022 | 90 | 2.630 |
Why?
|
| Myocardial Infarction | 14 | 2020 | 807 | 2.500 |
Why?
|
| Vascular Calcification | 13 | 2020 | 131 | 2.460 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 27 | 2022 | 373 | 2.390 |
Why?
|
| Gadolinium | 9 | 2022 | 88 | 2.190 |
Why?
|
| Magnetic Resonance Imaging, Cine | 17 | 2023 | 83 | 2.070 |
Why?
|
| Coronary Vessels | 19 | 2020 | 313 | 1.910 |
Why?
|
| Myocardium | 18 | 2022 | 1204 | 1.880 |
Why?
|
| Aortic Valve Stenosis | 10 | 2022 | 177 | 1.840 |
Why?
|
| Reproducibility of Results | 37 | 2021 | 2077 | 1.740 |
Why?
|
| Predictive Value of Tests | 34 | 2022 | 1465 | 1.660 |
Why?
|
| Myocardial Perfusion Imaging | 10 | 2021 | 100 | 1.370 |
Why?
|
| Humans | 138 | 2023 | 68618 | 1.340 |
Why?
|
| Aortography | 3 | 2021 | 72 | 1.330 |
Why?
|
| Aorta, Thoracic | 2 | 2021 | 211 | 1.250 |
Why?
|
| Organometallic Compounds | 5 | 2022 | 95 | 1.210 |
Why?
|
| Retrospective Studies | 56 | 2023 | 7277 | 1.180 |
Why?
|
| Male | 97 | 2023 | 37321 | 1.180 |
Why?
|
| Algorithms | 22 | 2022 | 1196 | 1.170 |
Why?
|
| Artificial Intelligence | 10 | 2023 | 159 | 1.140 |
Why?
|
| Myocardial Ischemia | 4 | 2021 | 172 | 1.140 |
Why?
|
| Female | 90 | 2023 | 38074 | 1.130 |
Why?
|
| Myocarditis | 3 | 2020 | 49 | 1.120 |
Why?
|
| Angiography, Digital Subtraction | 6 | 2020 | 63 | 1.110 |
Why?
|
| Prospective Studies | 22 | 2022 | 3705 | 1.100 |
Why?
|
| Aged | 57 | 2023 | 14862 | 1.080 |
Why?
|
| Machine Learning | 8 | 2022 | 170 | 1.060 |
Why?
|
| Image Processing, Computer-Assisted | 14 | 2021 | 689 | 1.050 |
Why?
|
| Diagnostic Imaging | 4 | 2021 | 201 | 1.030 |
Why?
|
| Middle Aged | 65 | 2023 | 21147 | 1.020 |
Why?
|
| Preoperative Care | 4 | 2021 | 275 | 1.010 |
Why?
|
| Lower Extremity | 6 | 2020 | 153 | 1.000 |
Why?
|
| Aortic Valve | 8 | 2022 | 249 | 1.000 |
Why?
|
| Plaque, Atherosclerotic | 8 | 2022 | 125 | 0.960 |
Why?
|
| Heart Diseases | 4 | 2022 | 276 | 0.950 |
Why?
|
| Imaging, Three-Dimensional | 7 | 2019 | 333 | 0.950 |
Why?
|
| Radiography, Dual-Energy Scanned Projection | 10 | 2019 | 92 | 0.930 |
Why?
|
| Respiration | 4 | 2019 | 91 | 0.890 |
Why?
|
| Gadolinium DTPA | 7 | 2015 | 48 | 0.850 |
Why?
|
| Image Enhancement | 4 | 2021 | 143 | 0.850 |
Why?
|
| Sensitivity and Specificity | 22 | 2021 | 1753 | 0.840 |
Why?
|
| Heart Neoplasms | 2 | 2020 | 33 | 0.820 |
Why?
|
| Arterial Occlusive Diseases | 2 | 2019 | 134 | 0.800 |
Why?
|
| Constriction, Pathologic | 7 | 2023 | 236 | 0.790 |
Why?
|
| Heart Atria | 5 | 2022 | 206 | 0.740 |
Why?
|
| Severity of Illness Index | 17 | 2022 | 1851 | 0.730 |
Why?
|
| Aorta, Abdominal | 2 | 2021 | 97 | 0.720 |
Why?
|
| Abdomen | 2 | 2019 | 80 | 0.710 |
Why?
|
| Feasibility Studies | 9 | 2021 | 652 | 0.710 |
Why?
|
| Thoracic Neoplasms | 1 | 2020 | 10 | 0.700 |
Why?
|
| Pelvis | 1 | 2019 | 38 | 0.690 |
Why?
|
| Radiation Dosage | 17 | 2022 | 419 | 0.680 |
Why?
|
| Aortic Aneurysm, Thoracic | 1 | 2021 | 134 | 0.670 |
Why?
|
| Thorax | 2 | 2023 | 49 | 0.670 |
Why?
|
| Cardiomyopathies | 4 | 2023 | 167 | 0.660 |
Why?
|
| Image Interpretation, Computer-Assisted | 5 | 2021 | 237 | 0.650 |
Why?
|
| Medical Oncology | 1 | 2020 | 110 | 0.650 |
Why?
|
| Phantoms, Imaging | 7 | 2023 | 189 | 0.650 |
Why?
|
| Four-Dimensional Computed Tomography | 1 | 2018 | 6 | 0.630 |
Why?
|
| Aortic Diseases | 1 | 2019 | 113 | 0.630 |
Why?
|
| Magnetic Resonance Spectroscopy | 7 | 2023 | 346 | 0.600 |
Why?
|
| Stents | 5 | 2022 | 657 | 0.580 |
Why?
|
| Aged, 80 and over | 16 | 2022 | 4848 | 0.570 |
Why?
|
| Heart Ventricles | 7 | 2022 | 738 | 0.550 |
Why?
|
| Observer Variation | 8 | 2018 | 330 | 0.550 |
Why?
|
| Nerve Net | 4 | 2021 | 181 | 0.530 |
Why?
|
| Adult | 35 | 2022 | 21403 | 0.520 |
Why?
|
| Meglumine | 1 | 2015 | 16 | 0.510 |
Why?
|
| Coronary Circulation | 2 | 2015 | 136 | 0.510 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2022 | 756 | 0.510 |
Why?
|
| Sarcoma, Ewing | 1 | 2015 | 26 | 0.510 |
Why?
|
| Iohexol | 6 | 2018 | 82 | 0.510 |
Why?
|
| Coronary Thrombosis | 1 | 2015 | 45 | 0.510 |
Why?
|
| Calcinosis | 4 | 2018 | 241 | 0.500 |
Why?
|
| Ventricular Dysfunction, Left | 2 | 2015 | 277 | 0.490 |
Why?
|
| Electrocardiography | 6 | 2022 | 601 | 0.480 |
Why?
|
| Diagnosis, Computer-Assisted | 3 | 2019 | 75 | 0.480 |
Why?
|
| Calcium | 6 | 2022 | 929 | 0.480 |
Why?
|
| Apolipoprotein E4 | 3 | 2021 | 31 | 0.480 |
Why?
|
| Eosinophilia | 1 | 2014 | 47 | 0.480 |
Why?
|
| Stroke Volume | 7 | 2023 | 586 | 0.480 |
Why?
|
| Heart Aneurysm | 1 | 2014 | 21 | 0.480 |
Why?
|
| Aspergillosis | 1 | 2014 | 20 | 0.480 |
Why?
|
| Prognosis | 12 | 2023 | 2093 | 0.460 |
Why?
|
| Percutaneous Coronary Intervention | 3 | 2022 | 137 | 0.440 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2014 | 116 | 0.440 |
Why?
|
| Ventricular Function, Left | 8 | 2023 | 481 | 0.430 |
Why?
|
| Fabry Disease | 2 | 2022 | 6 | 0.430 |
Why?
|
| Artifacts | 5 | 2019 | 125 | 0.420 |
Why?
|
| Heart Defects, Congenital | 4 | 2019 | 596 | 0.420 |
Why?
|
| Signal-To-Noise Ratio | 7 | 2021 | 93 | 0.410 |
Why?
|
| Young Adult | 13 | 2021 | 5717 | 0.370 |
Why?
|
| Time Factors | 10 | 2021 | 4655 | 0.360 |
Why?
|
| Dilatation, Pathologic | 2 | 2021 | 58 | 0.360 |
Why?
|
| Polymers | 1 | 2012 | 244 | 0.350 |
Why?
|
| Radiographic Image Enhancement | 5 | 2018 | 208 | 0.350 |
Why?
|
| Heart Valve Prosthesis Implantation | 2 | 2022 | 164 | 0.340 |
Why?
|
| Cardiac Imaging Techniques | 2 | 2021 | 35 | 0.340 |
Why?
|
| Swine | 5 | 2015 | 672 | 0.330 |
Why?
|
| Echocardiography | 4 | 2022 | 515 | 0.330 |
Why?
|
| Pulmonary Emphysema | 2 | 2020 | 71 | 0.330 |
Why?
|
| Defibrillators, Implantable | 2 | 2023 | 329 | 0.320 |
Why?
|
| Heart Failure | 3 | 2023 | 1180 | 0.310 |
Why?
|
| ROC Curve | 9 | 2019 | 392 | 0.310 |
Why?
|
| Multimodal Imaging | 3 | 2022 | 62 | 0.300 |
Why?
|
| Adolescent | 11 | 2021 | 8912 | 0.300 |
Why?
|
| Multidetector Computed Tomography | 2 | 2019 | 60 | 0.300 |
Why?
|
| Lung Diseases | 2 | 2020 | 175 | 0.300 |
Why?
|
| Presenilin-2 | 2 | 2017 | 6 | 0.300 |
Why?
|
| Presenilin-1 | 2 | 2017 | 28 | 0.290 |
Why?
|
| Kidney Transplantation | 3 | 2022 | 839 | 0.290 |
Why?
|
| Disease Models, Animal | 7 | 2019 | 2550 | 0.290 |
Why?
|
| Endovascular Procedures | 2 | 2021 | 366 | 0.280 |
Why?
|
| Lung Neoplasms | 1 | 2015 | 1173 | 0.270 |
Why?
|
| Radiography, Abdominal | 2 | 2017 | 57 | 0.270 |
Why?
|
| Hippocampus | 2 | 2021 | 471 | 0.260 |
Why?
|
| Acute Coronary Syndrome | 2 | 2017 | 195 | 0.250 |
Why?
|
| Cardiac-Gated Imaging Techniques | 4 | 2019 | 60 | 0.240 |
Why?
|
| Liver Diseases | 2 | 2016 | 193 | 0.240 |
Why?
|
| Risk Factors | 7 | 2023 | 5731 | 0.230 |
Why?
|
| Kidney Failure, Chronic | 2 | 2017 | 365 | 0.220 |
Why?
|
| Fibrosis | 4 | 2022 | 371 | 0.220 |
Why?
|
| Risk Assessment | 6 | 2021 | 2007 | 0.220 |
Why?
|
| Brain | 4 | 2017 | 2176 | 0.220 |
Why?
|
| Staining and Labeling | 2 | 2014 | 144 | 0.220 |
Why?
|
| Tin | 3 | 2018 | 16 | 0.220 |
Why?
|
| Bone Diseases, Metabolic | 1 | 2023 | 30 | 0.210 |
Why?
|
| Radiography, Thoracic | 2 | 2020 | 99 | 0.210 |
Why?
|
| Workflow | 2 | 2020 | 100 | 0.210 |
Why?
|
| Osteoporosis | 1 | 2023 | 88 | 0.200 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2023 | 117 | 0.200 |
Why?
|
| Iodine | 2 | 2019 | 42 | 0.200 |
Why?
|
| Angiography | 2 | 2021 | 194 | 0.200 |
Why?
|
| Fractures, Compression | 1 | 2021 | 11 | 0.190 |
Why?
|
| Heart Valve Diseases | 1 | 2022 | 123 | 0.190 |
Why?
|
| Reference Values | 1 | 2022 | 579 | 0.190 |
Why?
|
| Hematoma | 1 | 2021 | 47 | 0.190 |
Why?
|
| Neuropsychological Tests | 6 | 2021 | 517 | 0.190 |
Why?
|
| Anthracyclines | 1 | 2020 | 9 | 0.190 |
Why?
|
| Endoleak | 1 | 2021 | 23 | 0.190 |
Why?
|
| Spinal Fractures | 1 | 2021 | 43 | 0.180 |
Why?
|
| Injections | 3 | 2020 | 119 | 0.180 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2021 | 106 | 0.180 |
Why?
|
| Body Mass Index | 4 | 2016 | 867 | 0.180 |
Why?
|
| Pentetic Acid | 3 | 2016 | 18 | 0.180 |
Why?
|
| Treatment Outcome | 6 | 2022 | 7029 | 0.180 |
Why?
|
| Atrial Fibrillation | 1 | 2022 | 249 | 0.170 |
Why?
|
| Respiratory Function Tests | 1 | 2020 | 123 | 0.170 |
Why?
|
| Radiology | 1 | 2021 | 97 | 0.170 |
Why?
|
| Blood Flow Velocity | 2 | 2017 | 172 | 0.170 |
Why?
|
| Connectome | 1 | 2021 | 92 | 0.170 |
Why?
|
| Aortic Aneurysm, Abdominal | 1 | 2021 | 139 | 0.170 |
Why?
|
| Animals | 11 | 2020 | 20881 | 0.170 |
Why?
|
| Child | 5 | 2022 | 6405 | 0.170 |
Why?
|
| Mitral Valve | 1 | 2020 | 166 | 0.170 |
Why?
|
| Aorta | 2 | 2021 | 316 | 0.160 |
Why?
|
| Obesity | 2 | 2016 | 1076 | 0.160 |
Why?
|
| Tetrazolium Salts | 3 | 2015 | 36 | 0.160 |
Why?
|
| Anticoagulants | 1 | 2021 | 356 | 0.160 |
Why?
|
| Coronary Vessel Anomalies | 1 | 2019 | 45 | 0.160 |
Why?
|
| Renal Artery Obstruction | 1 | 2018 | 29 | 0.160 |
Why?
|
| Movement | 1 | 2019 | 179 | 0.160 |
Why?
|
| Smokers | 1 | 2020 | 200 | 0.150 |
Why?
|
| Doxorubicin | 1 | 2019 | 231 | 0.150 |
Why?
|
| Disease Progression | 1 | 2021 | 1038 | 0.150 |
Why?
|
| Dogs | 5 | 2020 | 490 | 0.150 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2020 | 207 | 0.140 |
Why?
|
| Diagnosis, Differential | 4 | 2014 | 1140 | 0.140 |
Why?
|
| Radiation Exposure | 4 | 2019 | 84 | 0.140 |
Why?
|
| Angina, Stable | 1 | 2016 | 13 | 0.140 |
Why?
|
| Amyloid beta-Protein Precursor | 1 | 2017 | 115 | 0.140 |
Why?
|
| Regional Blood Flow | 1 | 2017 | 168 | 0.140 |
Why?
|
| Area Under Curve | 4 | 2019 | 238 | 0.140 |
Why?
|
| Vascular Diseases | 1 | 2017 | 94 | 0.140 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2018 | 161 | 0.140 |
Why?
|
| Hemangiosarcoma | 1 | 2016 | 23 | 0.140 |
Why?
|
| Coronary Restenosis | 1 | 2016 | 42 | 0.140 |
Why?
|
| Magnetic Fields | 1 | 2016 | 21 | 0.130 |
Why?
|
| Follow-Up Studies | 5 | 2021 | 3259 | 0.130 |
Why?
|
| Graft Occlusion, Vascular | 1 | 2016 | 73 | 0.130 |
Why?
|
| Irritable Bowel Syndrome | 1 | 2015 | 10 | 0.130 |
Why?
|
| Amyloid beta-Peptides | 1 | 2017 | 191 | 0.130 |
Why?
|
| Chi-Square Distribution | 1 | 2017 | 546 | 0.130 |
Why?
|
| Apolipoproteins E | 1 | 2015 | 92 | 0.130 |
Why?
|
| Lung | 4 | 2022 | 849 | 0.130 |
Why?
|
| Mutation | 2 | 2017 | 1213 | 0.120 |
Why?
|
| Autopsy | 1 | 2014 | 56 | 0.120 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2015 | 100 | 0.120 |
Why?
|
| Chronic Disease | 2 | 2018 | 1330 | 0.120 |
Why?
|
| Fatal Outcome | 1 | 2014 | 164 | 0.120 |
Why?
|
| Cognition Disorders | 1 | 2017 | 342 | 0.120 |
Why?
|
| Amygdala | 1 | 2016 | 159 | 0.120 |
Why?
|
| Emotions | 1 | 2016 | 244 | 0.120 |
Why?
|
| Analysis of Variance | 1 | 2017 | 1040 | 0.120 |
Why?
|
| Blood Vessel Prosthesis | 1 | 2015 | 182 | 0.120 |
Why?
|
| Liver | 2 | 2018 | 1118 | 0.120 |
Why?
|
| Decision Making | 1 | 2017 | 410 | 0.120 |
Why?
|
| Necrosis | 1 | 2014 | 239 | 0.120 |
Why?
|
| Cerebrovascular Circulation | 1 | 2015 | 296 | 0.120 |
Why?
|
| Liver Neoplasms | 1 | 2018 | 334 | 0.120 |
Why?
|
| Software | 3 | 2022 | 418 | 0.110 |
Why?
|
| Case-Control Studies | 4 | 2019 | 1553 | 0.110 |
Why?
|
| Cognition | 1 | 2017 | 513 | 0.110 |
Why?
|
| Hemodynamics | 1 | 2016 | 705 | 0.110 |
Why?
|
| Random Allocation | 1 | 2014 | 442 | 0.110 |
Why?
|
| Biopsy | 1 | 2014 | 540 | 0.110 |
Why?
|
| Microspheres | 1 | 2012 | 59 | 0.100 |
Why?
|
| Coloring Agents | 1 | 2012 | 66 | 0.100 |
Why?
|
| In Vitro Techniques | 1 | 2012 | 765 | 0.090 |
Why?
|
| Adipose Tissue | 2 | 2022 | 221 | 0.090 |
Why?
|
| Postoperative Complications | 1 | 2018 | 1615 | 0.090 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2012 | 239 | 0.090 |
Why?
|
| Brain Mapping | 3 | 2017 | 532 | 0.080 |
Why?
|
| Depression | 1 | 2016 | 943 | 0.080 |
Why?
|
| Heterozygote | 2 | 2021 | 174 | 0.080 |
Why?
|
| Rest | 2 | 2019 | 78 | 0.080 |
Why?
|
| Heart Rate | 2 | 2023 | 568 | 0.080 |
Why?
|
| Ischemia | 2 | 2022 | 229 | 0.080 |
Why?
|
| Filtration | 2 | 2018 | 61 | 0.070 |
Why?
|
| Aneurysm, False | 1 | 2007 | 60 | 0.070 |
Why?
|
| Registries | 2 | 2021 | 733 | 0.070 |
Why?
|
| Cardiac Catheterization | 2 | 2022 | 419 | 0.070 |
Why?
|
| Germany | 2 | 2016 | 67 | 0.070 |
Why?
|
| Adenosine | 2 | 2016 | 165 | 0.070 |
Why?
|
| Survival Rate | 2 | 2019 | 1056 | 0.060 |
Why?
|
| Vasodilator Agents | 2 | 2016 | 138 | 0.060 |
Why?
|
| Myocardial Reperfusion | 2 | 2015 | 32 | 0.060 |
Why?
|
| Absorptiometry, Photon | 1 | 2023 | 83 | 0.050 |
Why?
|
| Tomography | 1 | 2022 | 9 | 0.050 |
Why?
|
| Hypertrophy | 1 | 2022 | 89 | 0.050 |
Why?
|
| Ventricular Function, Right | 1 | 2023 | 103 | 0.050 |
Why?
|
| Lumbar Vertebrae | 1 | 2023 | 112 | 0.050 |
Why?
|
| Bone Density | 1 | 2023 | 159 | 0.050 |
Why?
|
| Radiologists | 1 | 2022 | 35 | 0.050 |
Why?
|
| Morbidity | 1 | 2022 | 130 | 0.050 |
Why?
|
| Purines | 1 | 2021 | 39 | 0.050 |
Why?
|
| Infant | 2 | 2019 | 2891 | 0.050 |
Why?
|
| Child, Preschool | 2 | 2019 | 3187 | 0.050 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2021 | 137 | 0.050 |
Why?
|
| X-Ray Microtomography | 1 | 2021 | 50 | 0.050 |
Why?
|
| Acceleration | 1 | 2021 | 37 | 0.050 |
Why?
|
| Muscles | 1 | 2021 | 158 | 0.050 |
Why?
|
| Inpatients | 1 | 2022 | 208 | 0.050 |
Why?
|
| Pyrazoles | 1 | 2021 | 190 | 0.050 |
Why?
|
| Time | 1 | 2020 | 57 | 0.040 |
Why?
|
| Positron-Emission Tomography | 1 | 2021 | 160 | 0.040 |
Why?
|
| Pattern Recognition, Automated | 1 | 2020 | 70 | 0.040 |
Why?
|
| Chest Pain | 1 | 2021 | 151 | 0.040 |
Why?
|
| Automation | 1 | 2019 | 45 | 0.040 |
Why?
|
| Cerebral Hemorrhage | 1 | 2021 | 198 | 0.040 |
Why?
|
| Asia | 1 | 2019 | 59 | 0.040 |
Why?
|
| North America | 1 | 2019 | 112 | 0.040 |
Why?
|
| Sphingolipids | 1 | 2022 | 337 | 0.040 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2021 | 185 | 0.040 |
Why?
|
| Europe | 1 | 2019 | 196 | 0.040 |
Why?
|
| Recurrence | 1 | 2021 | 948 | 0.040 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2019 | 82 | 0.040 |
Why?
|
| Carbon Dioxide | 1 | 2018 | 78 | 0.040 |
Why?
|
| Renal Artery | 1 | 2018 | 29 | 0.040 |
Why?
|
| Carotid Stenosis | 1 | 2019 | 163 | 0.040 |
Why?
|
| Injections, Intra-Arterial | 1 | 2017 | 30 | 0.040 |
Why?
|
| Arteries | 1 | 2018 | 108 | 0.040 |
Why?
|
| Efferent Pathways | 1 | 2017 | 15 | 0.040 |
Why?
|
| Phenotype | 1 | 2021 | 947 | 0.040 |
Why?
|
| Auditory Pathways | 1 | 2017 | 20 | 0.040 |
Why?
|
| Exercise Test | 1 | 2019 | 242 | 0.040 |
Why?
|
| Visual Pathways | 1 | 2017 | 31 | 0.040 |
Why?
|
| Apolipoprotein E2 | 1 | 2017 | 8 | 0.040 |
Why?
|
| Mental Status and Dementia Tests | 1 | 2017 | 9 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2021 | 1054 | 0.040 |
Why?
|
| Isolated Heart Preparation | 1 | 2017 | 8 | 0.040 |
Why?
|
| Delivery of Health Care | 1 | 2021 | 445 | 0.040 |
Why?
|
| Pulmonary Artery | 1 | 2019 | 323 | 0.040 |
Why?
|
| Forecasting | 1 | 2018 | 277 | 0.040 |
Why?
|
| Sus scrofa | 1 | 2017 | 74 | 0.040 |
Why?
|
| Breath Holding | 1 | 2016 | 8 | 0.040 |
Why?
|
| Hepatic Artery | 1 | 2016 | 25 | 0.040 |
Why?
|
| Portal Vein | 1 | 2016 | 46 | 0.040 |
Why?
|
| Arterial Pressure | 1 | 2017 | 47 | 0.030 |
Why?
|
| Auditory Perception | 1 | 2017 | 89 | 0.030 |
Why?
|
| Executive Function | 1 | 2017 | 106 | 0.030 |
Why?
|
| Triiodobenzoic Acids | 1 | 2016 | 28 | 0.030 |
Why?
|
| Reference Standards | 1 | 2016 | 115 | 0.030 |
Why?
|
| Hematemesis | 1 | 2016 | 14 | 0.030 |
Why?
|
| Visual Perception | 1 | 2017 | 124 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2023 | 2279 | 0.030 |
Why?
|
| Patient Care Planning | 1 | 2016 | 108 | 0.030 |
Why?
|
| Models, Cardiovascular | 1 | 2017 | 133 | 0.030 |
Why?
|
| Hemoptysis | 1 | 2016 | 28 | 0.030 |
Why?
|
| Cone-Beam Computed Tomography | 1 | 2016 | 52 | 0.030 |
Why?
|
| Cost-Benefit Analysis | 1 | 2018 | 504 | 0.030 |
Why?
|
| United States | 2 | 2019 | 7367 | 0.030 |
Why?
|
| Magnetic Resonance Imaging, Interventional | 1 | 2015 | 5 | 0.030 |
Why?
|
| Hospitalization | 1 | 2021 | 978 | 0.030 |
Why?
|
| User-Computer Interface | 1 | 2017 | 230 | 0.030 |
Why?
|
| Attention | 1 | 2017 | 225 | 0.030 |
Why?
|
| Aortic Aneurysm | 1 | 2016 | 77 | 0.030 |
Why?
|
| Organ Size | 1 | 2015 | 242 | 0.030 |
Why?
|
| Healthy Volunteers | 1 | 2015 | 78 | 0.030 |
Why?
|
| Neural Pathways | 1 | 2017 | 324 | 0.030 |
Why?
|
| Body Temperature | 1 | 2015 | 116 | 0.030 |
Why?
|
| Statistics as Topic | 1 | 2015 | 219 | 0.030 |
Why?
|
| Renal Dialysis | 1 | 2016 | 174 | 0.030 |
Why?
|
| Demography | 1 | 2015 | 279 | 0.030 |
Why?
|
| Drug Administration Schedule | 1 | 2016 | 567 | 0.030 |
Why?
|
| Polymorphism, Genetic | 1 | 2015 | 301 | 0.030 |
Why?
|
| Motor Activity | 1 | 2017 | 621 | 0.030 |
Why?
|
| Recovery of Function | 1 | 2017 | 506 | 0.030 |
Why?
|
| Inflammation | 1 | 2020 | 1030 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2016 | 880 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2017 | 786 | 0.030 |
Why?
|
| Ultrasonography | 1 | 2015 | 453 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2016 | 1046 | 0.030 |
Why?
|
| Electroencephalography | 1 | 2015 | 418 | 0.030 |
Why?
|
| Logistic Models | 1 | 2016 | 1420 | 0.030 |
Why?
|
| Alzheimer Disease | 1 | 2017 | 565 | 0.030 |
Why?
|
| Cardiovascular Diseases | 1 | 2019 | 940 | 0.030 |
Why?
|
| Infant, Newborn | 1 | 2017 | 2455 | 0.020 |
Why?
|
| Reperfusion | 1 | 2011 | 78 | 0.020 |
Why?
|
| Angioplasty, Balloon | 1 | 2011 | 110 | 0.020 |
Why?
|
| South Carolina | 1 | 2016 | 2752 | 0.020 |
Why?
|
| Neoplasms | 1 | 2019 | 1667 | 0.020 |
Why?
|
| Models, Statistical | 1 | 2011 | 448 | 0.020 |
Why?
|